quality measure2021-10-21repealed
Maßnahmen zur Qualitätssicherung nach § 136a Absatz 5 SGB V: Onasemnogen-Abeparvovec bei spinaler Muskelatrophie
Open official decision page ↗
G-BA source · retrieved 2026-08-05
Decision orientation
What the G-BA did
3 cited claims
Each claim links to the official G-BA page or an exact PDF page range.
Official metadata
- Decision date
- 2021-10-21
- Effective
- aufgehoben
- Action type
- quality measure
- Committee
- Arzneimittel
Case context
Listed normative targets
directiveATMP-Qualitätssicherungs-Richtlinie
A listed target is not treated as a new directive version unless an official version source exists.
Official document package